Concord medical services holdings limited (CCM) 2024Q2 financial report shows revenue of 109.41M CNY, with a YoY growth rate of -23.09%. This clearly indicates that Concord medical services holdings limited (CCM) is facing severe revenue challenges and a significant deterioration. To better understand the business situation, investors are advised to look beyond the revenue YoY, and closely examine trends in net profit, operating profit, and gross margin. In addition, leveraging third-party data such as Growin AI Value Analysis will provide a more comprehensive assessment of the operational pressure and potential financial risks faced by Concord medical services holdings limited (CCM).